Published in

Springer Nature [academic journals on nature.com], Cell Research, 4(32), p. 404-406, 2022

DOI: 10.1038/s41422-022-00617-x

Links

Tools

Export citation

Search in Google Scholar

Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO